{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:11:23Z","timestamp":1780413083084,"version":"3.54.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>We have previously hypothesized that well-differentiated papillary mesothelial tumor (WDPMT) consists of 2 morphologically identical lesions, one of which is true WDPMT, while the other is a form of mesothelioma in situ. Here, we report 8 examples of the latter phenomenon, 3 with pleural disease (2 men\/1 woman, ages 66 to 78\u00a0y); and 5 with peritoneal disease (all women, ages 31 to 81\u00a0y). At presentation the pleural cases all had effusions but no evidence of pleural tumor on imaging. Four of the 5 peritoneal cases had ascites as the initial finding and all 4 had nodular lesions that by imaging and\/or direct inspection were thought to represent a diffuse peritoneal malignancy. The fifth peritoneal case presented with an umbilical mass. Microscopically, the pleural and peritoneal lesions looked like diffuse WDPMT, but all had lost BAP1. Occasional microscopic foci of superficial invasion were present in 3\/3 pleural cases, while single nodules of invasive mesothelioma and\/or occasional foci of superficial microscopic invasion were found in all of the peritoneal cases. The pleural tumor patients developed what clinically appeared to be invasive mesothelioma at 45, 69, and 94 months. Four\/five peritoneal tumor patients underwent cytoreductive surgery and heated intraperitoneal chemotherapy. Three with follow-up data are alive without recurrence at 6, 24, and 36 months; 1 patient refused treatment but is alive at 24 months. We conclude that mesothelioma in situ morphologically mimicking WDPMT is strongly associated with the synchronous or metachronous development of invasive mesothelioma, but that these lesions appear to progress very slowly.<\/jats:p>","DOI":"10.1097\/pas.0000000000002033","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T12:01:13Z","timestamp":1678104073000},"page":"611-617","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor"],"prefix":"10.1097","volume":"47","author":[{"given":"Francoise","family":"Galateau-Salle","sequence":"first","affiliation":[{"name":"MESOPATH College, MESONAT, MESOBANK, L\u00e9on B\u00e9rard Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"MacNeill","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hofman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-0025, CHU Nice, FHU OncoAge, Nice Pasteur Hospital, C\u00f4te d\u2019Azur University, Nice"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Sequeiros","sequence":"additional","affiliation":[{"name":"MESOPATH, MESOBANK, Department of BioPathology, L\u00e9on B\u00e9rard Center, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sagan","sequence":"additional","affiliation":[{"name":"CHU Department of Pathology, University Hospital, Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Le Stang","sequence":"additional","affiliation":[{"name":"Cancer Registry, CHU Poitiers, University of Medicine-Pharmacy, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41379-022-01082-y","article-title":"Well differentiated papillary mesothelial tumor: a new name and new problems","volume":"35","author":"Churg","year":"2022","journal-title":"Mod Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","volume":"79","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal mesothelioma: national practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:32Z","timestamp":1749416432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002033","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}